Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2019

01-03-2019 | Multiple Myeloma | Letter to the Editor

Prominent regression of corneal crystalline deposits in multiple myeloma after treatment with proteasome inhibitor

Authors: Sayo Maeno, Shizuka Koh, Michiko Ichii, Yoshinori Oie, Kohji Nishida, Yuzuru Kanakura

Published in: Annals of Hematology | Issue 3/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Milman T, Kao AA, Chu D, Gorski M, Steiner A, Simon CZ, Shih C, Aldave AJ, Eagle RC Jr, Jakobiec FA, Udell I (2015) Paraproteinemic keratopathy: the expanding diversity of clinical and pathologic manifestations. Ophthalmology 122:1748–1756CrossRefPubMed
2.
Busch C, Koh S, Oie Y, Ichii M, Kanakura Y, Nishida K (2017) In vivo confocal microscopy of multiple myeloma associated crystalline keratopathy. Am J Hematol 92:593–594CrossRefPubMed
3.
Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N (2016) Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol 91:1123–1128CrossRefPubMed
4.
Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Blade J, Fermand JP, Hassoun H, Heffner L, Kukreti V, Vescio RA, Pei L, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL (2014) Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis. Blood 124:2498–2506CrossRefPubMedPubMedCentral
5.
Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, van de Donk NWCJ, Bruno B, Sezer O, Broijl A, Bringhen S, Beksac M, Larocca A, Hajek R, Musto P, Johnsen HE, Morabito F, Ludwig H, Cavo M, Einsele H, Sonneveld P, Dimopoulos MA, Palumbo A, on behalf of the European Myeloma Network (2015) European myeloma network guidelines for the management of multiple myeloma-related complications. Haematologica 100:1254–1266CrossRefPubMedPubMedCentral
6.
Buerk BM, Tu E (2002) Confocal microscopy in multiple myeloma crystalline keratopathy. Cornea 21:619–620CrossRefPubMed
7.
Houben N, Foets B (2006) Confocal microscopy in multiple myeloma associated crystalline keratopathy: case report. Bull Soc Belg Ophthalmol 300:13–17
Metadata
Title
Prominent regression of corneal crystalline deposits in multiple myeloma after treatment with proteasome inhibitor
Authors
Sayo Maeno
Shizuka Koh
Michiko Ichii
Yoshinori Oie
Kohji Nishida
Yuzuru Kanakura
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03614-0

Other articles of this Issue 3/2019

Annals of Hematology 3/2019 Go to the issue

Original Article

Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim

Original Article

Prognosis of autoimmune hemolytic anemia in critically ill patients

Original Article

Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for booster

Review Article

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML

Original Article

Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases

Original Article

Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits